Literature DB >> 17116667

In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori.

Sotirios Paraschos1, Prokopios Magiatis, Sofia Mitakou, Kalliopi Petraki, Antonios Kalliaropoulos, Petros Maragkoudakis, Andreas Mentis, Dionyssios Sgouras, Alexios-Leandros Skaltsounis.   

Abstract

The extracts and pure major constituents of Chios mastic gum (resin of Pistacia lentiscus var. chia) were tested for their activities against Helicobacter pylori. A total mastic extract without polymer (TMEWP) was prepared after removal of the contained insoluble polymer in order to ameliorate solubility and enhance in vivo activity. Administration of TMEWP to H. pylori SS1-infected mice over the period of 3 months with an average dose of 0.75 mg/day led to an approximately 30-fold reduction in the H. pylori colonization (1.5 log CFU/g of tissue). However, no attenuation in the H. pylori-associated chronic inflammatory infiltration and the activity of chronic gastritis was observed. To further characterize potential active mastic constituents, the TMEWP was separated into an acidic and a neutral fraction. Both were extensively characterized by nuclear magnetic resonance and mass spectroscopy to elucidate the structure of the components contained within each fraction. After chromatographic separation, the acid fraction gave the major triterpenic acids, while the neutral fraction gave several triterpenic alcohols and aldehydes. Mastic extracts and isolated pure triterpenic acids were tested for in vitro activity against a panel of 11 H. pylori clinical strains. The acid fraction was found to be the most active extract (minimum bactericidal concentration [MBC], 0.139 mg/ml), and the most active pure compound was isomasticadienolic acid (MBC, 0.202 mg/ml [0.443 mM]). Our results show that administration of TMEWP may be effective in reducing H. pylori colonization and that the major triterpenic acids in the acid extract may be responsible for such an activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17116667      PMCID: PMC1797732          DOI: 10.1128/AAC.00642-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori.

Authors:  P Marone; L Bono; E Leone; S Bona; E Carretto; L Perversi
Journal:  J Chemother       Date:  2001-12       Impact factor: 1.714

Review 2.  Helicobacter infection and gastric neoplasia.

Authors:  Richard M Peek; Jean E Crabtree
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

3.  Differential susceptibility of inbred mouse strains to Helicobacter pylori infection.

Authors:  M Mähler; C Janke; S Wagner; H J Hedrich
Journal:  Scand J Gastroenterol       Date:  2002-03       Impact factor: 2.423

4.  Two novel cytotoxic and antimicrobial triterpenoids from Pseudolarix kaempferi.

Authors:  S P Yang; J M Yue
Journal:  Bioorg Med Chem Lett       Date:  2001-12-17       Impact factor: 2.823

5.  Further development of the Helicobacter pylori mouse vaccination model.

Authors:  P Sutton; J Wilson; A Lee
Journal:  Vaccine       Date:  2000-06-01       Impact factor: 3.641

6.  A new 7,8-euphadien-type triterpenoid from Brackenridgea nitida and Bleasdalea bleasdalei that inhibits DNA polymerase beta.

Authors:  J Z Deng; S R Starck; D A Sun; M Sabat; S M Hecht
Journal:  J Nat Prod       Date:  2000-10       Impact factor: 4.050

7.  Anti-AIDS agents. 48.(1) Anti-HIV activity of moronic acid derivatives and the new melliferone-related triterpenoid isolated from Brazilian propolis.

Authors:  J Ito; F R Chang; H K Wang; Y K Park; M Ikegaki; N Kilgore; K H Lee
Journal:  J Nat Prod       Date:  2001-10       Impact factor: 4.050

8.  Mastic gum has no effect on Helicobacter pylori load in vivo.

Authors:  James R Bebb; Nathalie Bailey-Flitter; Dlawer Ala'Aldeen; John C Atherton
Journal:  J Antimicrob Chemother       Date:  2003-07-29       Impact factor: 5.790

9.  In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota.

Authors:  D Sgouras; P Maragkoudakis; K Petraki; B Martinez-Gonzalez; E Eriotou; S Michopoulos; G Kalantzopoulos; E Tsakalidou; A Mentis
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

10.  Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice.

Authors:  Michael F Loughlin; Dlawer A Ala'Aldeen; Peter J Jenks
Journal:  J Antimicrob Chemother       Date:  2003-02       Impact factor: 5.790

View more
  33 in total

Review 1.  Non-pharmacological treatment of Helicobacter pylori.

Authors:  Haim Shmuely; Noam Domniz; Jacob Yahav
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

2.  Pharmacophore-driven identification of PPARγ agonists from natural sources.

Authors:  Rasmus K Petersen; Kathrine B Christensen; Andreana N Assimopoulou; Xavier Fretté; Vassilios P Papageorgiou; Karsten Kristiansen; Irene Kouskoumvekaki
Journal:  J Comput Aided Mol Des       Date:  2010-11-11       Impact factor: 3.686

Review 3.  Immunometabolism in biofilm infection: lessons from cancer.

Authors:  Rasoul Mirzaei; Niloofar Sabokroo; Yaghoub Ahmadyousefi; Hamid Motamedi; Sajad Karampoor
Journal:  Mol Med       Date:  2022-01-29       Impact factor: 6.354

4.  Composition and enantiomeric analysis of the essential oil of the fruits and the leaves of Pistacia vera from Greece.

Authors:  Anastasia Tsokou; Katerina Georgopoulou; Eleni Melliou; Prokopios Magiatis; Eugenia Tsitsa
Journal:  Molecules       Date:  2007-06-30       Impact factor: 4.411

Review 5.  Treatment of Helicobacter pylori infection: Current and future insights.

Authors:  Maliheh Safavi; Reyhaneh Sabourian; Alireza Foroumadi
Journal:  World J Clin Cases       Date:  2016-01-16       Impact factor: 1.337

6.  Anti-inflammatory activity of Chios mastic gum is associated with inhibition of TNF-alpha induced oxidative stress.

Authors:  Angelike Triantafyllou; Alfiya Bikineyeva; Anna Dikalova; Rafal Nazarewicz; Stamatios Lerakis; Sergey Dikalov
Journal:  Nutr J       Date:  2011-06-06       Impact factor: 3.271

7.  Camphene, a plant-derived monoterpene, reduces plasma cholesterol and triglycerides in hyperlipidemic rats independently of HMG-CoA reductase activity.

Authors:  Ioanna Vallianou; Nikolaos Peroulis; Panayotis Pantazis; Margarita Hadzopoulou-Cladaras
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

8.  Fractionation of Mastic Gum in Relation to Antimicrobial Activity.

Authors:  Mohammad Sharif Sharifi; Stuart Loyd Hazell
Journal:  Pharmaceuticals (Basel)       Date:  2009-04-01

9.  A transcriptomic computational analysis of mastic oil-treated Lewis lung carcinomas reveals molecular mechanisms targeting tumor cell growth and survival.

Authors:  Panagiotis Moulos; Olga Papadodima; Aristotelis Chatziioannou; Heleni Loutrari; Charis Roussos; Fragiskos N Kolisis
Journal:  BMC Med Genomics       Date:  2009-12-15       Impact factor: 3.063

10.  In vivo efficacy of gum obtained pistacia atlantica in experimental treatment of cutaneous leishmaniasis.

Authors:  M Taran; M Mohebali; J Esmaeli
Journal:  Iran J Public Health       Date:  2010-03-31       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.